Clinical Trial Update: Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating concurrent treatment of cervical cancer using locally applied CIGB-300 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Cervix
• Squamous Cell Carcinoma of the Cervix

Drugs mentioned

• CIGB-300 (CIGB-300)

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Squamous Cell Carcinoma of the Cervix, Adenocarcinoma of the Cervix | Phase 2 | Status: COMPLETED